May 12, 2023 04:05PM
Mar 27, 2023 04:05PM
Nov 14, 2022 04:41PM
Aug 31, 2022 05:30PM
Aug 15, 2022 04:05PM
May 16, 2022 04:15PM
Mar 31, 2022 04:15PM Interpace Biosciences Announces Full Year and Fourth Quarter 2021 Financial and Business Results
Nov 10, 2021 04:05PM
Aug 10, 2021 04:05PM
May 11, 2021 04:47PM
Mar 31, 2021 05:20PM
Feb 16, 2021 09:21PM
Feb 16, 2021 09:21PM
Jan 20, 2021 08:30AM Interpace Biosciences Announces Third Quarter 2020 Financial and Business Results and Completion of $5 Million Bridge Loan
Jan 20, 2021 08:30AM
Oct 20, 2020 08:00AM
Oct 20, 2020 08:00AM
Jun 25, 2020 04:59PM
Jun 25, 2020 04:59PM
Apr 22, 2020 04:05PM
Apr 22, 2020 04:05PM Interpace Biosciences Announces Full Year and Fourth Quarter 2019 Financial and Business Results and Preliminary Q1-2020 Results
Jan 13, 2020 06:55AM
Jan 13, 2020 06:55AM
Nov 13, 2019 04:40PM
Nov 13, 2019 04:40PM
Oct 29, 2019 06:55AM
Oct 24, 2019 04:15PM
Oct 24, 2019 04:15PM Cancer Genetics, Inc. Announces Strategic Transactions
Oct 24, 2019 06:55AM
Oct 17, 2019 06:55AM
Aug 19, 2019 05:15PM
Aug 19, 2019 05:15PM
Aug 13, 2019 08:15AM
Aug 13, 2019 08:15AM
Jul 22, 2019 06:56AM Interpace Diagnostics (IDXG) Reports New Agreement with SelectHealth
Jul 22, 2019 06:55AM
Jul 22, 2019 06:55AM
Jul 18, 2019 06:56AM
Jul 18, 2019 06:55AM
Jul 18, 2019 06:55AM
Jul 15, 2019 04:12PM
Jul 15, 2019 04:10PM Interpace Diagnostics Acquires Cancer Genetics’ Biopharma Services Business Supported by Investment from Ampersand Capital Partners
Jul 15, 2019 04:10PM
May 13, 2019 04:05PM
May 13, 2019 04:05PM
Jan 29, 2019 04:20PM
Jan 29, 2019 04:20PM
Jan 25, 2019 06:05AM
Jan 25, 2019 06:00AM Interpace Diagnostics Announces Pricing of $7.0 Million Public Offering of Common Stock
Jan 25, 2019 06:00AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All